FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to treating lower extremity ischemia. That is ensured by administering a suspension of mononuclear self-specific marrow cells through a microcatheter directly into the ischemic region after performing an angioplasty if a steno-occlusive involvement of peripheral arteries.
EFFECT: method for delivery the cell material provides treating the lower extremity ischemia effectively by the pronounced enhancement of the regional blood flow.
1 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF LOWER LIMBS ISCHEMIC DISEASES | 2015 |
|
RU2633487C2 |
| METHOD OF TREATMENT OF ISCHEMIC ANGIOPATHY OF LOWER EXTREMITY VESSELS | 2017 |
|
RU2649498C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC LOWER EXTREMITY ISCHEMIA CASES | 2005 |
|
RU2286159C1 |
| COMBINED METHOD OF TREATMENT OF PATIENTS WITH CRITICAL ISCHEMIA OF THE LOWER EXTREMITIES | 2023 |
|
RU2796189C1 |
| METHOD OF COMBINED SURGICAL STIMULATION OF LOWER EXTREMITY CHRONIC LOWER LIMB NEOANGIOGENESIS | 2018 |
|
RU2703395C1 |
| METHOD FOR TREATING THE CASES OF NON-OPERABLE CARDIOLOGIC PATIENTS | 2004 |
|
RU2250772C1 |
| METHOD OF TREATING LOWER LIMB ISCHEMIA | 2008 |
|
RU2376995C1 |
| METHOD OF TREATING SUBCRITICAL LIMB ISCHEMIA ACCOMPANYING CHRONIC OBLITERATING DISEASES OF LOWER-LIMB ARTERIES | 2014 |
|
RU2570285C1 |
| COMBINED METHOD OF TREATMENT OF PATIENTS WITH CRITICAL ISCHEMIA OF LOWER EXTREMITIES | 2023 |
|
RU2808920C1 |
| METHOD OF LIMB TERMINAL ISCHEMIA TREATMENT | 2008 |
|
RU2369399C1 |
